Cannabis Global, Inc. (CBGL)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 4, 2026, 3:59 PM EST
Cannabis Global Revenue
In the fiscal year ending August 31, 2022, Cannabis Global had annual revenue of $1.06M, down -33.89%. Cannabis Global had revenue of $-930.96K in the quarter ending August 31, 2022.
Revenue
1.06M
Revenue Growth
-33.89%
P/S Ratio
0.65
Revenue / Employee
352.80K
Employees
3
Market Cap
684.20K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2022 | 1.06M | -542.64K | -33.89% |
| Aug 31, 2021 | 1.60M | 1.57M | 5,828.89% |
| Aug 31, 2020 | 27.00K | - | - |
| Aug 31, 2019 | - | - | - |
| Aug 31, 2018 | - | - | - |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tian'an Pharmaceutical | 10.65M |
| Pure Harvest Corporate Group | 2.48M |
| Nutra Pharma | 392.15K |
| CBD Life Sciences | 178.45K |
| TransGlobal Assets | 91.35K |
| Branded Legacy | 87.65K |
| Grapefruit USA | 34.85K |
| Premier Biomedical | 14.28K |